» Articles » PMID: 26497635

PRC2 Mediated H3K27 Methylations in Cellular Identity and Cancer

Overview
Publisher Elsevier
Specialty Cell Biology
Date 2015 Oct 27
PMID 26497635
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The Polycomb Repressive Complex 2 (PRC2) is a multiprotein chromatin modifying complex that is essential for vertebrate development and differentiation. It is composed of a trimeric core of SUZ12, EED and EZH1/2 and is responsible for catalysing both di-methylation and tri-methylation of Histone H3 at lysine 27 (H3K27me2/3). Both H3K27 methylations contribute to the role of PRC2 in maintaining cellular identity. In all cell types, the H3K27me3 modification is associated with repression of genes encoding regulators of alternative lineages. The less well-characterised H3K27me2 modification is ubiquitous throughout the genome and is thought to act like a protective blanket to maintain the repression of non-H3K27me3 associated genes and cell-type-specific enhancers of alternative lineages. Recent cancer genome sequencing studies highlighted that several genes encoding PRC2 components as well as Histone H3 are mutated in multiple cancer types. Intriguingly, these cancers have changes in the global levels of the H3K27me2 and H3K27me3 modifications as well as genome-wide redistributions. Exciting new studies suggest that these changes confer context dependent blocks in cellular differentiation and increased vulnerability to aberrant cancer signalling pathways.

Citing Articles

A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis.

Gubbiotti M, McCutcheon I, Rao P, Genovese G, Wang L, Tarasov A Acta Neuropathol Commun. 2025; 13(1):12.

PMID: 39833894 PMC: 11748356. DOI: 10.1186/s40478-025-01929-w.


HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.

Minisini M, Mascaro M, Brancolini C Cancer Drug Resist. 2024; 7:46.

PMID: 39624079 PMC: 11609180. DOI: 10.20517/cdr.2024.103.


WTAP-dependent N6-methyladenosine methylation of lncRNA TEX41 promotes renal cell carcinoma progression.

Zhou Z, Chen X, Wang H, Ding L, Wang M, Li G Sci Rep. 2024; 14(1):24742.

PMID: 39433619 PMC: 11494115. DOI: 10.1038/s41598-024-76326-9.


How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia.

Mirchandani A, Sanchez-Garcia M, Walmsley S Nat Rev Immunol. 2024; 25(3):161-177.

PMID: 39349943 DOI: 10.1038/s41577-024-01087-5.


Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).

Qu P, Li L, Jin Q, Liu D, Qiao Y, Zhang Y Int J Mol Med. 2024; 54(5).

PMID: 39301658 PMC: 11414529. DOI: 10.3892/ijmm.2024.5428.